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     Adenoviruses are recognized as common human pathogens that are responsible for a wide variety of 
infectious syndromes. Bone marrow transplant patients are prone to life threatening opportunistic infections 
like adenoviruses. The nested polymerase chain reaction has provided an alternative, sensitive diagnostic 
method for detection of Adenoviruses. In this study we developed PCR from hexon genes as rapid 
diagnostic method of Advs infections on different clinical samples. Adenovirus infections was defined as the 
presence of DNA in the blood, urine, stool, or respiratory lavage from bone marrow transplant patients. Two 
sets of primers (Group specific primers and internal primers) were required to optimize the PCR protocol. 
This highly sensitive method could detect different types of Advs in two separate sets of PCR. 
Therfore,DNA amplification in BMT patients would be valuable screening way to evaluate bone marrow 
transplant recipients. Early detection of Advs by PCR assay is important to asymptomatic infections or 
preventing aggressive antiviral thearapy. 
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INTRODUCTION 
     Human Adenoviruses (HAdvs) are known as a 
family of Adenoviridae [1]. which can cause 
variety of human disease. These microorganisms 
divided into six species, A-F with 51 serotypes. 
The new Adenovirus species has been isolated 
from gastroenteritis patient type G with serotype 
52 [2]. Adenoviruses as viral pathogens produce 
major complicated problems in 
immunocompromised or transplant patients. 
Rapid and proper diagnosis of HAdvs infection is 
critical and controversial in bone marrow 
transplant recipients. DNA amplification method 
is preferentially diagnostic technique to apply for 
clinical samples [3]. In this study we developed 
nested PCR from hexon genes to detect different 
HAdvs from stool, urine, respiratory lavage in 
bone marrow transplant recipients. The PCR 
assay has provided significant advantages in 
sensitivity over antigen detection or culture 
methods. Thus, with the primer sets used in 
amplification process proved capability of rapid 
identification the human Adenoviruses species 
[4]. Here, we collected clinical specimens from 
bone marrow transplant recipients, then extracted 
DNA to identify the infected peoples . 
 DNA extraction from blood, serum, cell 
suspension 
In this method we used QIA Gen Kit, Germany, 
then transferred sample into a 1.5 ml eppendorf 
tube so 200ul from cell suspension poured into 
200ul PBS. Added 25 ul QIA Gen protease stock 
solution and 200ul buffer into the sample. Then 
mixed immediately by vortex for 15 seconds. 
Incubated at -70° c for 10 min. For serum, blood, 
plasma the amount of 210ul isopropranol was 
added to the cell suspension and mixed by vortex. 
Placed a QIA amp spin column in a 2ml 
collection tube. Applied the mixture from above 
step to the column without moistening the rim, 
closed the cap, centrifuged at 8000rpm. After 
several washing steps, DNA was eluted with 200 
μl of preheated buffer or distilled water. For urine 
DNA extraction, the viral RNA Kit and in DNA 
preparation in feces the diluted sodium chloride 
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were used, and sterilized by filtration (0.22μM 
filter).  
PCR primers 
Two Adenovirus primers were chosen from hexon 
genes. These primers made a PCR fragment with 
134 base pairs.[5,6,7,8,9] Then two pairs primers, 
one pair as general primers or group specific and 
the others as internal to amplify two fragments. 
One fragment with 300 bp and these products 
were used for second PCR to make a 243 bp 
fragment. The sequence of the primers as follows: 
5‘ATG-ACT-TTT-GAG-GTG-GAT-CCC-ATG-GA3‘                                                26mer                    
5‘GCC-GAG-AAG-GGC-GTG-CGC-AGG-TA   3‘                                                  23 mer                       
Primer sequence in PCR to amplify a 134bp fragment 
5‘GCC-GCA-GTG-GTC-TTA-CAT-GCA-CAT-C3‘                                                    25mer 
5‘CAG-CAC-GCC-GCG-GAT-GTC-AAA-GT3‘                                                         23mer 
General primers(Group specific Primers) to make a 300bp fragment 
5‘CCA-GGA-CGC-CTC-GGA-GTA-CCT3‘                                                             21mer 
5‘TGG-AAG-CCA-TAT-CAA-GCA-CAC3‘                                                             21mer 
Internal primers produce a 243bp fragment 
Table 1. The PCR components 
Primer AdenoQCR4R 50 pmol/µl  each 2.0 µl 
Primer AdenoQCR1 50pmol/µl each 2.0 µl 
Dinucleotide Triphosphate(dNtp) 1.5٭mM(mixed) 8.0µl 
10x PCR buffer(15 mMMgcl2) 15mMmgcl,500mMKCL,100mMtris,0.1%gelatin 5.0 µl 
Taq polymerase 5u/µl (Boehringer manheim) 1.3 µl 
Double Distilled Water DDW 26.7 µl 
 stock solution of dNTP(contained 1.5mM each deoxynucleotide triphosphate dNTP in strile distilled water٭
 
Table 2. PCR PROGRAMME TABLE 
First cycle  94° c        10min 
Second cycle 94° c 45second 
Annealing  tempreture 55° c 20 second 







Figure 1. The different DNA dilution in first column is 
marker(123bp DNA Ladder), second column 10-1,10-
2,10-3,10-4,10-5,10-6,10-7,10-8,10-9 negative control. 
The first PCR with 300bp is detected. 
 
 
















negative control.(two 123bpDNA marker).  




                              Figure 3. General PCR (300bp) of different types of Adenoviruses from left to right  
              Ade Type 4,6,9,10,19,13,24,16,17,18,20,22,26,28,29,30,33,negative control,123bp DNA marker. 
                                      
Figure 4. In the figure ,upper part, nested PCR from pcr product 243bp detected. 
The first column is marker and the second Ade Type 4,6,9,10,19,13,24,16,17,18,20,22,26,28,29,30,33,negative control. 
The lower part the same as above with 300bp in general PCR.       
 
Reaction mixture is shown in table 1. The PCR 
with two groups specific primers was performed. 
It made 300bp with all groups of Adenoviruses 
(A-F). The nested PCR was done from PCR 
product of Ad2,3,5,7,21,25,32, with using the 
internal primers. The number of cycle was 30. 
The nested PCR program was the same as above 
unless the 45° c for the annealing temperature. 
Determination of PCR sensitivity 
We extracted DNA and cleaned with purification 

















.  The PCR was run with the general 
primers and diluted DNA. (figure 1)This figure 
demonstrates the PCR sensitivity.  
To apply the method to detect different types of 
Adenoviruses, DNA extracted from cell culture 
supernatant (by phenol-chlroform 
isoamylalcohole), two PCR , first in general 
primers to make a fragment with 300bp, then 
using the PCR product directly in the nested PCR 
to make a 243bp fragment. Different types 
including 4, 6, 9, 10, 13, 19, 24, 16, 17, 18, 20, 
22, 26, 28, 29, 30, 33 were detected. (Figure 3, 4) 
 
MATERIALS AND METHODS 
     Clinical samples were collected by bone 
marrow transplant unit(BMTU) in Essen 
University Clinic Centre(Germany). Different 
samples, urine, stool, respiratory lavage from 
eight transplant recipients in different times were 
prepared. All the samples sequentially collected 
before and after a months of transplant. Then the 
results were evaluated. Totally eighty four 
samples were selected from eight patients. The 
clinical materials were cultured in KB cells 
(human aliquates were cultured into carcinoma 
cells in MEM media) stored in -20° freezer. To 
make positive viral samples, one ml of 
Ad2,Ad14,Ad5,Ad25,Ad21,Ad7,Ad4,Ad3,and 
2ml of Ad32,Ad37,ad8,Ad31,were added into KB 
cells. For negative control only MEM culture 
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Sample Preparation  
      Before amplification, Adenovirus DNA 
should be free of capsid or contamination. To 100 
µl of sample (already aliquot into 100 µl) 25 µl of 
lysis buffer and 1µl of proteinase K(25mg/ml) 
was added. Incubate in 50° c water bath for one 
hour. Then heated at 65° c for 20 min to inactivate 
proteinase K. An equal volume of phenol 
chloroform isoamylalchol was added. For one to 
two minutes vortexed. Centrifuged at 12000 in 
two minutes.The upper layer removed and added 
an equal volume of chloroform-isoamylalchohol. 
Then vortexed and centrifuged as above. 
Removed the upper layer and or low in virus load, 
DNA should be concentrated with ethanol 
method. Added 1/10 volume of 3M sodium 
acetate, ph 5.2. Added 2 volume of ethanol(100%) 
in -20° c, mixed and centrifuged in 12000g for 30 
min. in 4° c. Removed supernatant , washed the 
pellet twice with ethanol 70% (-20° c).  
PCR 
The nested PCR in 30 cycles with denaturation 
temperature 94°C and annealing tem.55° C in first 
run but 45° C in second run detected all different 
types of Adenoviruses .The sensitivity of two 
PCR with the serial dilution of DNA were 
determined. We prepared different clinical 
specimens from bone marrow transplant unit of 
eight transplanted patients.  
 
RESULTS 
     Two PCR designed in this study to detect 
human Adenoviruses. The hexon gene was chosen 
as the target as more is known about this gene 
than any other Adenoviral gene. With two primers 
Adenovirus QCR4R 5‘ATG-ACT-TTT-GAG-
GTG-GAT-CCC-ATG-GA 3‘ ,  5‘GCC-GAG-
AAG-GGC-GTG-CGC-AGG-TA 3‘ from hexon 
gene could detect a 134 base pair fragment of four 
serotypes of Adenovirus (Ad2 ,Ad5 ,Ad14 
,Ad25). There was no amplification in negative 
control(cells without adding virus) or in 
specificity control (herpes simplex virus added to 
the cells) . Two sets of primers , one as group 
specific and the other internal primers were 
designed . The general primers 5‘ TTG-ACA-
TCC-GCG-TGC-TG 3‘ ,TAT-CAT-TTT-GAC-
CTT-GAG-C- 3‘detected a 300bp fragments of all 
groups of Adenoviruses (A-F) .The internal 
primers 5‘ CCA-GGA-CGC-CTC-GGA-GTA-
CCT 3‘ , TGG-AAG-CCA-TAT-CAA-GCA-
CAC 3‘ were made a 243 bp fragments of PCR 
product in first run .  
 
Table 3. Patient results from eight BMT recipients. 
Patient name ZM. Date of birth 04/09/1956 . Transplanted on 29/07/1997 
Start date and end 




urine stool serum 
25/07/97 negative --------- -------- -------- 
28/07/97 ---------- posirive -------- -------- 
29/07/97 ---------- negative -------- -------- 
31/07/97 ---------- ---------- negative positive 
04/08/97 ---------- positive negative negative 
08/08/97 positive ---------- --------- -------- 
11/08/97 positive negative --------- negative 
Table 3a 
 
Patient name WE. Date of birth 11/12/46 transplanted in 28/07/97 
Start date and end 
date of sample 
preparation 
BAL urine stool serum 
18/07/97 positive positive negative -------- 
24/07/97 negative negative -------- -------- 
31/07/97 positive ---------- --------- -------- 
04/08/97 ---------- positive negative -------- 
07/08/97 negative negative -------- -------- 
Table 3b 
Patient name PTH. date of birth 23/03/55 transplanted 04/08/97 
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Start date and end 
date of sample 
preparation 
BAL urine stool serum 
28/07/97 neg neg --------- -------- 
08/08/97 neg pos --------- neg 
Table 3c 
 
Patient name AD. Date of birth 24/07/52 transplanted 30/07/97 
Start date and end 
date of sample 
preparation 
BAL urine stool serum 
15/07/97 pos pos neg ------- 
18/07/97 ------- ------ pos ------- 
22/07/97 pos pos ------- ------- 
24/07/97 neg neg ------- ------- 
27/07/97 neg neg ------- ------- 
29/07/97 ------- ------- neg ------- 
04/08/97 pos neg neg ------- 
11/08/97 pos ------- ------- ------- 
Table3d 
 
Patient name BH .date of birth 30/05/48 transplanted 15/07/97 
Patient Start date 
and end date of 
sample preparation 
BAL urine stool serum 
08/07/97 pos neg neg ------ 
15/07/97 pos pos neg ------ 
21/07/97 pos ------- neg ------- 
27/07/97 neg neg ------- ------- 
04/08/97 pos neg neg ------- 
11/08/97 ------- ------- neg ------- 
18/07/97 ------ pos ------- -------- 
Table3e 
 
Patient name KG .date of birth 30/01/50 transplanted 24/07/97 
Patient Start date 
and end date of 
sample preparation 
BAL urine stool serum 
18/07/97 neg pos neg ------- 
21/07/97 pos -------- ------- -------- 
 
27/07/97 ------- pos -------- -------- 
29/07/97 -------- -------- neg ---------- 
04/08/97 pos neg --------- ---------- 
09/08/97 -------- -------- neg ---------- 
11/08/97 pos -------- --------- ---------- 
Table3f 
 
Patient name BE .date of birth 30/08/51 transplanted 05/08/97 
Patient Start date 
and end date of 
sample preparation 
BAL urine stool -------- 
29/07/97 pos pos neg -------- 
04/08/97 pos neg -------- -------- 
11/08/97 pos neg neg -------- 
Table3g 
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Patient name HE .date of birth 20/02/41 transplanted 28/07/97 
Patient Start date 
and end date of 
sample preparation 
BAL urine stool serum 
27/07/97 pos neg neg -------- 
29/07/97 ------- -------- neg -------- 
04/08/97 neg neg ------ -------- 
11/08/97 pos neg neg -------- 
Table3 h 
 
One type specific PCR performed in all positive 
specimens . Using specific primers type 31 could 
detect none of positive samples. Figures  5, 6, 7,8 
have shown the above positive results on gel. We 
added Adenovirus 2 in all negative urine samples 
as inhibitory control. Then extracted DNA by 
viral RNA kit. All negative urine specimens were 
positive . Figure 8 represented the results.  None 
of type specific primers for Ad1,2,4,5 were 






Figure 5. PCR from clinical samples in BMT patients. First column 123bp DNA Ladder, No.1 positive  urine sample 
in ZM, No.2Positive urine sample with faint band, No.3 negative urine sample in AD, No.4  negative urine sample in 
WE,No.5 negative urine sample in AD,No.6 negative urine sample in PTH,No.7 positive urine sample inKG,No.8 
negative urine sample in ZM,No.9 negative respiratory sample in KG, No.10 negative respiratory sample in 
ZM,No.11positive respiratory sample in KG,No.12negative respiratory sample in AD,No.13.negative respiratory 
sample in WE,No.14.positive respiratory sample in HE,No.15.negative respiratory sample in AD,No.16.positive urine 
sample in BH by adding Ad25 ,No.17.negative respiratory sample in BH,No.18.negative urine sample in 
BH,No.19.negative urine sample in HE,No.20.negative urine sample in BH,No.21 positive stool sample in AD,No.22 
negative stool sample in BH,No.23.negative stool sample in BH,No.24.negative stool sample in different date in 
BH,No.25.positive stool sample plus Ad25in BH,No.26.negative stool sample in WE,No.27.negative stool sample in 
HE,No.28.negative stool sample in BE,No.29.negative stool sample in AD,No.30.negative stool sample in 
KG,No.31Ad2positive control,No.32.negative control,No.33.negative control for second PCR. 
 
 




    Figure 6. PCR from urine positive samples.No.1 positive BH urine sample,No.2. positive AD urine 
sample,No.3.positive WE urine sample,No.4 positive KG urine sample,No.5.positive AD urine sample in different 
date,No.6 positive ZM urine sample,No.7positive BH urine sample,No.8positive BE urine sample,No.9 negative AD 





 Figure 7. PCR from PCR product in different clinical samples, in lower side Before marker negative result then 














Figure 8. The upper side is the nested PCR with 243bp positive specimen in clinical patient  samples ,in lower side 
before marker ,negative PCR then neg.control and pos.control.plus negative results which added Ad2 to the samples to 
make it positive in first PCR as inhibitory control stored on ice. It could be stored in -70° c. For diluted specimens or 
small volume. 
.   
DISCUSSION 
      There are overall sequence homology less 
than 25℅ between the 6 species of Adenoviruses 
[10]. Most of the studies are based on 
amplification of highly conserved region of 
Adenovirus genome. The sequence information of 
hexon gene in different types of Adenoviruses 
explains the 50℅ nucleotide homology. The 
incidence of Adenovirus infection following the 
bone marrow transplantation was high in first 6 
months. [11]. The patients with Advs infection are 
susceptible to multiple opportunistic co-infections 
which contribute severe disease. Infection is 
spread through aerosolized droplets with 
breathing or nosocomially [12].The risk factors in 
post bone marrow transplant Advs infectivity 
could be types of immunosuppressive therapy, 
and transplantation from unrelated donors [13]. 
The highly progress of molecular diagnostic 
techniques of viral infections which are the gold 
standard methods used in the lab. These 
techniques are the most efficient way to identify 
the viral agents in making quick decisions of 
therapeutic measures for avoiding the 
transmission of the disease [14]. There are several 
mechanisms may explain the viral infections in 
immunocompromised peoples like reactivation of 
the virus or transmission from donor to recipient 
[15]. To our knowledge , none of our positive 
results were strain Adv31 which others reported 
an outbreak of Adv31 infections in 2003 with 
nosocomial origin. Adenoviruses produce 
nosocomial infections which can be controlled by 
using adequate disinfection of instruments or 
using gloves to examine patients. Even in 
swimming pools with inadequate chlorination can 
cause infections [16]. Although in this study , the 
presence of virus in asymptomatic feature in spite 
of inhibitors to taq polymerase in urine samples, 
two steps PCR detected all positive specimens. 
The importance of early diagnosis is establishing 
the procedures of the steroid therapy [17]. The 
present of Adenoviral DNA in stool samples 
allows the early differentiation of gastroenteritis 
infections or graft-versus-host-disease(GVHD)in 
transplant patients. The hexon gene makes the 
large amount of the virus surface and it has been 
shown to contain the group specific and the type 
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specific antigenic parts of the gene.(18) The two 
steps PCR which described here with small PCR 
product without storage problems of clinical 
samples ,thus offers significant improvement in 
speed and sensitivity in comparing with 
conventional methods. Using the sensitive 
methods such as PCR in diagnosis could be 
helpful to distinguish different stages of infection 
by quantitate the genome copies in our 
experiments [19]. The nested PCR provides a 
unique method to detect previously unrecognized 
Adenoviruses even presence of one copy of Advs. 
is shown. This method are not able to support the 
association between clinical syndromes and 
various human Ads. Serotypes because real time 
PCR with cloning fragment overlapping internally 
control to known Ads.types [20].There are various 
reports of Advs in immunocompromised 
transplant recipients. Most of these infections 
were types 2,5,11,12,31,35 but in our experiments 
none of the positive samples were Advs 31. This 
type of Adenovirus needs more investigation to 
prevent infections in bone marrow transplant 
patients. Conclusion 
 
In our study, the optimized PCR detected different 
types of Advs in clinical specimens. This highly 
sensitive diagnostic method described even 
presence 
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